James Investment Research Inc. Acquires 21,169 Shares of Cabot Corporation (CBT)

James Investment Research Inc. increased its position in shares of Cabot Corporation (NYSE:CBT) by 417.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,242 shares of the specialty chemicals company’s stock after buying an additional 21,169 shares during the period. James Investment Research Inc.’s holdings in Cabot Corporation were worth $1,402,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. World Asset Management Inc raised its stake in Cabot Corporation by 0.5% in the first quarter. World Asset Management Inc now owns 4,333 shares of the specialty chemicals company’s stock worth $260,000 after buying an additional 20 shares during the last quarter. State Treasurer State of Michigan raised its stake in Cabot Corporation by 0.8% in the first quarter. State Treasurer State of Michigan now owns 25,280 shares of the specialty chemicals company’s stock worth $1,515,000 after buying an additional 200 shares during the last quarter. Capstone Asset Management Co. raised its stake in Cabot Corporation by 4.0% in the second quarter. Capstone Asset Management Co. now owns 5,442 shares of the specialty chemicals company’s stock worth $291,000 after buying an additional 210 shares during the last quarter. Advantus Capital Management Inc raised its stake in Cabot Corporation by 2.8% in the first quarter. Advantus Capital Management Inc now owns 7,963 shares of the specialty chemicals company’s stock worth $477,000 after buying an additional 216 shares during the last quarter. Finally, Liberty Mutual Group Asset Management Inc. increased its position in Cabot Corporation by 0.8% in the first quarter. Liberty Mutual Group Asset Management Inc. now owns 27,852 shares of the specialty chemicals company’s stock worth $1,670,000 after buying an additional 228 shares during the period. 85.39% of the stock is owned by institutional investors.

Shares of Cabot Corporation (NYSE:CBT) traded up 0.06% during midday trading on Monday, hitting $54.50. The stock had a trading volume of 125,761 shares. Cabot Corporation has a 52-week low of $46.88 and a 52-week high of $61.34. The stock has a market cap of $3.40 billion, a PE ratio of 14.59 and a beta of 1.05. The firm has a 50 day moving average price of $53.82 and a 200-day moving average price of $55.77.

Cabot Corporation (NYSE:CBT) last issued its quarterly earnings results on Monday, May 1st. The specialty chemicals company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.85 by $0.02. Cabot Corporation had a net margin of 9.33% and a return on equity of 16.83%. The firm had revenue of $678 million during the quarter, compared to analyst estimates of $637.57 million. During the same quarter in the prior year, the business posted $0.70 earnings per share. Cabot Corporation’s revenue for the quarter was up 19.4% compared to the same quarter last year. Equities analysts predict that Cabot Corporation will post $3.47 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Friday, August 25th will be given a $0.315 dividend. This represents a $1.26 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Wednesday, August 23rd. Cabot Corporation’s payout ratio is currently 33.69%.

A number of research firms have recently issued reports on CBT. ValuEngine downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Friday. Zacks Investment Research downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. BidaskClub upgraded Cabot Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, July 6th. Jefferies Group LLC set a $68.00 target price on Cabot Corporation and gave the company a “buy” rating in a research report on Thursday, June 8th. Finally, Aegis reiterated a “hold” rating on shares of Cabot Corporation in a research report on Wednesday, May 31st. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $59.67.

Cabot Corporation Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.